PETMED EXPRESS, INC. Cost of Revenue
PETMED EXPRESS, INC. (PETS) reported Cost of Revenue of $29.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- PETMED EXPRESS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $29.68M, a 19.29% decline year-over-year.
- PETMED EXPRESS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $31.95M, a 18.64% decline year-over-year.
- PETMED EXPRESS, INC. cost of goods and services sold for the quarter ending 2025-06-30 was $36.78M, a 22.03% decline year-over-year.
- PETMED EXPRESS, INC. cost of goods and services sold for the quarter ending 2025-03-31 was $35.56M, a 22.64% decline year-over-year.
- PETMED EXPRESS, INC. cost of goods and services sold for fiscal 2025 was $157.84M, a 16.63% decline from fiscal 2024.
- PETMED EXPRESS, INC. cost of goods and services sold for fiscal 2024 was $189.33M, a 10.67% increase from fiscal 2023.
- PETMED EXPRESS, INC. cost of goods and services sold for fiscal 2023 was $171.07M, a 12.43% decline from fiscal 2022.
- PETMED EXPRESS, INC. cost of goods and services sold for fiscal 2022 was $195.34M, a 10.91% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $29.68M 10-Q · filed 2026-08-13 | |||||||
| 2025-09-30 | $31.95M 10-Q · filed 2025-12-19 | $68.73M 10-Q · filed 2025-12-19 | $104.29M derived: sum of 3 quarters · filed 2026-08-13 | $140.12M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $36.78M 10-Q · filed 2026-08-13 | $72.34M derived: sum of 2 quarters · filed 2026-08-13 | $108.17M derived: sum of 3 quarters · filed 2026-08-13 | $147.44M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $35.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-14 | $71.39M derived: sum of 2 quarters · filed 2026-02-05 | $110.67M derived: sum of 3 quarters · filed 2026-02-05 | $157.84M 10-K · filed 2025-10-14 | ||||
| 2024-12-31 | $35.83M 10-Q · filed 2026-02-05 | $38.08M 10-Q · filed 2025-02-10 | $75.10M derived: sum of 2 quarters · filed 2026-02-05 | $122.27M 10-Q · filed 2026-02-05 | $130.31M 10-Q · filed 2025-02-10 | $168.24M derived: sum of 4 quarters · filed 2026-02-05 | ||
| 2024-09-30 | $39.27M 10-Q · filed 2025-12-19 | $42.26M 10-Q · filed 2024-11-07 | $86.44M 10-Q · filed 2025-12-19 | $92.24M 10-Q · filed 2024-11-07 | $132.41M derived: sum of 3 quarters · filed 2025-12-19 | $176.66M derived: sum of 4 quarters · filed 2025-12-19 | ||
| 2024-06-30 | $47.17M 10-Q · filed 2025-12-19 | $49.98M 10-Q · filed 2024-08-07 | $93.14M derived: sum of 2 quarters · filed 2025-12-19 | $137.39M derived: sum of 3 quarters · filed 2025-12-19 | $185.59M derived: sum of 4 quarters · filed 2025-12-19 | |||
| 2024-03-31 | $45.97M derived: 10-K 12 month − 10-K 9 month · filed 2025-10-14 | $90.22M derived: sum of 2 quarters · filed 2025-10-14 | $138.42M derived: sum of 3 quarters · filed 2025-10-14 | $189.33M 10-K · filed 2025-10-14 | $202.42M 10-K · filed 2024-06-14 | |||
| 2023-12-31 | $44.25M 10-K · filed 2025-10-14 | $47.43M 10-Q · filed 2024-04-15 | $92.45M derived: sum of 2 quarters · filed 2025-10-14 | $143.36M 10-K · filed 2025-10-14 | $154.09M 10-Q · filed 2024-04-15 | $184.24M derived: sum of 4 quarters · filed 2025-10-14 | ||
| 2023-09-30 | $48.20M 10-K · filed 2025-10-14 | $50.94M 10-Q · filed 2023-10-31 | $99.11M 10-K · filed 2025-10-14 | $106.66M 10-Q · filed 2023-10-31 | $139.99M derived: sum of 3 quarters · filed 2025-10-14 | $180.66M derived: sum of 4 quarters · filed 2025-10-14 | ||
| 2023-06-30 | $50.91M 10-K · filed 2025-10-14 | $55.72M 10-Q · filed 2023-08-02 | $91.79M derived: sum of 2 quarters · filed 2025-10-14 | $132.45M derived: sum of 3 quarters · filed 2025-10-14 | $175.48M derived: sum of 4 quarters · filed 2025-10-14 | |||
| 2023-03-31 | $40.88M derived: 10-K 12 month − 10-K 9 month · filed 2025-10-14 | $81.55M derived: sum of 2 quarters · filed 2025-10-14 | $124.57M derived: sum of 3 quarters · filed 2025-10-14 | $171.07M 10-K · filed 2025-10-14 | $185.84M 10-K · filed 2023-05-23 | |||
| 2022-12-31 | $40.67M 10-K · filed 2025-10-14 | $43.63M 10-Q · filed 2023-02-07 | $83.69M derived: sum of 2 quarters · filed 2025-10-14 | $130.19M 10-K · filed 2025-10-14 | $140.82M 10-Q · filed 2023-02-07 | $176.79M derived: sum of 4 quarters · filed 2025-10-14 | ||
| 2022-09-30 | $43.03M 10-K · filed 2025-10-14 | $46.94M 10-Q · filed 2022-11-08 | $89.52M 10-K · filed 2025-10-14 | $97.19M 10-Q · filed 2022-11-08 | $136.13M derived: sum of 3 quarters · filed 2025-10-14 | $179.12M derived: sum of 4 quarters · filed 2025-10-14 | ||
| 2022-06-30 | $46.49M 10-K · filed 2025-10-14 | $50.24M 10-Q · filed 2022-08-02 | $93.10M derived: sum of 2 quarters · filed 2025-10-14 | $136.09M derived: sum of 3 quarters · filed 2025-10-14 | $184.30M derived: sum of 4 quarters · filed 2025-10-14 | |||
| 2022-03-31 | $46.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-14 | $89.60M derived: sum of 2 quarters · filed 2024-06-14 | $137.81M derived: sum of 3 quarters · filed 2024-06-14 | $195.34M 10-K · filed 2024-06-14 | ||||
| 2021-12-31 | $42.99M 10-Q · filed 2023-02-07 | $91.20M derived: sum of 2 quarters · filed 2023-02-07 | $148.74M 10-Q · filed 2023-02-07 | $199.89M derived: sum of 4 quarters · filed 2024-04-15 | ||||
| 2021-09-30 | $48.21M 10-Q · filed 2022-11-08 | $105.74M 10-Q · filed 2022-11-08 | $156.90M derived: sum of 3 quarters · filed 2024-04-15 | $203.17M derived: sum of 4 quarters · filed 2024-04-15 | ||||
| 2021-06-30 | $57.53M 10-Q · filed 2022-08-02 | $108.69M derived: sum of 2 quarters · filed 2024-04-15 | $154.96M derived: sum of 3 quarters · filed 2024-04-15 | $207.38M derived: sum of 4 quarters · filed 2024-04-15 | ||||
| 2021-03-31 | $51.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-15 | $97.43M derived: sum of 2 quarters · filed 2024-04-15 | $149.85M derived: sum of 3 quarters · filed 2024-04-15 | $219.27M 10-K/A · filed 2024-04-15 | ||||
| 2020-12-31 | $46.27M 10-Q · filed 2022-02-04 | $98.69M derived: sum of 2 quarters · filed 2022-02-04 | $168.11M 10-Q · filed 2022-02-04 | $220.71M derived: sum of 4 quarters · filed 2022-05-24 | ||||
| 2020-09-30 | $52.42M 10-Q · filed 2021-11-02 | $121.84M 10-Q · filed 2021-11-02 | $174.44M derived: sum of 3 quarters · filed 2022-05-24 | $216.66M derived: sum of 4 quarters · filed 2022-05-24 | ||||
| 2020-06-30 | $69.42M 10-Q · filed 2021-07-30 | $122.02M derived: sum of 2 quarters · filed 2022-05-24 | $164.24M derived: sum of 3 quarters · filed 2022-05-24 | $214.17M derived: sum of 4 quarters · filed 2022-05-24 | ||||
| 2020-03-31 | $52.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-24 | $94.82M derived: sum of 2 quarters · filed 2022-05-24 | $144.75M derived: sum of 3 quarters · filed 2022-05-24 | $202.88M 10-K · filed 2022-05-24 | ||||
| 2019-12-31 | $42.22M 10-Q · filed 2021-01-26 | $92.15M derived: sum of 2 quarters · filed 2021-01-26 | $150.28M 10-Q · filed 2021-01-26 | $194.12M derived: sum of 4 quarters · filed 2021-05-25 | ||||
| 2019-09-30 | $49.93M 10-Q · filed 2020-11-03 | $108.06M 10-Q · filed 2020-11-03 | $151.90M derived: sum of 3 quarters · filed 2021-05-25 | $192.59M derived: sum of 4 quarters · filed 2021-05-25 | ||||
| 2019-06-30 | $58.13M 10-Q · filed 2020-08-03 | $101.97M derived: sum of 2 quarters · filed 2021-05-25 | $142.66M derived: sum of 3 quarters · filed 2021-05-25 | $188.80M derived: sum of 4 quarters · filed 2021-05-25 | ||||
| 2019-03-31 | $43.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-25 | $84.53M derived: sum of 2 quarters · filed 2021-05-25 | $130.67M derived: sum of 3 quarters · filed 2021-05-25 | $188.10M 10-K · filed 2021-05-25 | ||||
| 2018-12-31 | $40.69M 10-Q · filed 2020-01-28 | $86.83M derived: sum of 2 quarters · filed 2020-01-28 | $144.26M 10-Q · filed 2020-01-28 | $186.67M derived: sum of 4 quarters · filed 2020-05-26 | ||||
| 2018-09-30 | $46.14M 10-Q · filed 2019-10-30 | $103.58M 10-Q · filed 2019-10-30 | $145.98M derived: sum of 3 quarters · filed 2020-05-26 | $184.15M derived: sum of 4 quarters · filed 2020-05-26 | ||||
| 2018-06-30 | $57.44M 10-Q · filed 2019-07-30 | $99.84M derived: sum of 2 quarters · filed 2020-05-26 | $138.00M derived: sum of 3 quarters · filed 2020-05-26 | $181.24M derived: sum of 4 quarters · filed 2020-05-26 | ||||
| 2018-03-31 | $42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-26 | $80.57M derived: sum of 2 quarters · filed 2020-05-26 | $123.80M derived: sum of 3 quarters · filed 2020-05-26 | $175.99M 10-K · filed 2020-05-26 | ||||
| 2017-12-31 | $38.17M 10-Q · filed 2019-01-29 | $81.40M derived: sum of 2 quarters · filed 2019-01-29 | $133.59M 10-Q · filed 2019-01-29 | |||||
| 2017-09-30 | $43.23M 10-Q · filed 2018-10-30 | $95.42M 10-Q · filed 2018-10-30 | ||||||
| 2017-06-30 | $52.19M 10-Q · filed 2018-07-31 | |||||||
| 2017-03-31 | $169.86M 10-K · filed 2019-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |